|
1)
Spatial and temporal expression
of POF1B, a gene expressed in epithelia.
Rizzolio F, Bione S, Villa A,
Berti E, Cassetti A, Bulfone A, Tribioli C, Toniolo D.
Gene Expr Patterns.
2007 Feb;7(4):529-34
2)
Epigenetic control of the
critical region for premature ovarian failure on autosomal genes
translocated to the X chromosome: a hypothesis.
Rizzolio F, Sala C, Alboresi
S, Bione S, Gilli S, Goegan M, Pramparo T, Zuffardi O, Toniolo D.
Hum Genet.
2007 May;121(3-4):441-50. Epub 2007 Jan 31.
3)
X chromosome and ovarian
failure.
Toniolo D, Rizzolio F.
Semin Reprod Med.
2007 Jul;25(4):264-71. Review.
4)
Highly conserved non-coding
sequences and the 18q critical region for short stature: a common
mechanism of disease?
Rizzolio F, Bione S, Sala C,
Tribioli C, Ciccone R, Zuffardi O, di Iorgi N, Maghnie M, Toniolo D.
PLoS One.
2008 Jan 23;3(1):e1460.
5)
Epigenetic analysis of the
critical region I for premature ovarian failure: demonstration of a
highly heterochromatic domain on the long arm of the mammalian X
chromosome.
Rizzolio F, Pramparo T, Sala
C, Zuffardi O, De Santis L, Rabellotti E, Calzi F, Fusi F, Bellazzi R,
Toniolo D.
J Med Genet.
2009 Sep;46(9):585-92. Epub 2008 Jul 15.
6)
RB gene family: genome-wide
ChIP approaches could open undiscovered roads.
Rizzolio F, Esposito L, Muresu
D, Fratamico R, Jaraha R, Caprioli GV, Giordano A.
J Cell Biochem.
2010 Apr 1;109(5):839-43. Review.
7)
CDK inhibitors: from the bench
to clinical trials.
Rizzolio F, Tuccinardi T,
Caligiuri I, Lucchetti C, Giordano A.
Curr Drug Targets.
2010 Mar;11(3):279-90. Review.
8)
Adenosine receptor ligands in
clinical trials.
Rizzolio F, La Montagna R,
Tuccinardi T, Russo G, Caputi M, Giordano A.
Curr Top Med Chem.
2010;10(10):1036-45. Review.
9)
R-Roscovitine (Seliciclib)
prevents DNA damage-induced cyclin A1 upregulation and hinders
non-homologous end-joining (NHEJ) DNA repair.
Federico M, Symonds CE,
Bagella L, Rizzolio F, Fanale D, Russo A, Giordano A.
Mol Cancer.
2010 Aug 4;9:208.
|